Disorders of Lymphatic Vessels

Rook's Textbook of Dermatology: Eighth Edition

Volumn 3, Issue , 2010, Pages 2253-2283

  Mortimer, Peter S ^a,b,c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acquired lymphatic abnormalities; Chronic oedema and lymphoedema; Clinical diagnosis of lymphoedema; Differential diagnosis of swollen limb; Localized lymphoedema; Lymphatic malformations, lymphangioma and lymphangiectasia lymphatic malformations (lymphangioma); Lymphatic tumours; Lymphatic vessel disorder; Midline lymphoedema

Indexed keywords

EID: 84888665925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch48     Document Type: Chapter

References (297)

1. Yoffey JM, Courtice JM. Lymphatics, Lymph and the Lymphomyeloid Complex. New York: Academic Press, 1970.
2. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007; 170: 774-86.
3. Baluk P, Tammela T, Ator E et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005; 115: 247-57.
4. Xu X, Lin H, Lv H et al. Adventitial lymphatic vessels-an important role in atherosclerosis. Med Hypotheses 2007; 69: 1238-41.
5. Pedica F, Ligorio C, Tonelli P et al. Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch 2008; 452: 57-63.
6. Polzer K, Baeten D, Soleiman A et al. TNF blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis 2008; 67: 1610-6.
7. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230-4.
8. Sabin FR. On the origin of the lymphatic system from the veins and the development of lymph hearts and thoracic duct in the pig. Am J Anat 1902; i: 3671.
9. Sabin FR. On the development of the superficial lymphatics in the skin of the pig. Am J Anat 1904; 9: 43-91.
10. Huntington GS, McClure CFW. The anatomy and development of the jugular lymph sacs in the domestic cat. Am J Anat 1908; 22: 1-19.
11. Buttler K, Ezaki T, Wilting J. Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. BMC Dev Biol 2008; 8: 43.
12. Religa P, Cao R, Bjorndahl M et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 2005; 106: 4184-90.
13. Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci 1995; 92: 3566-70.
14. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82: 673-700.
15. Wigle JT, Oliver G. Prox-1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-78.
16. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalingin control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-71.
17. Saaristo A, Veikkola T, Tammela T et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002; 196: 719-30.
18. Nagy JA, Vasile E, Feng D et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002; 196: 1497-506.
19. Cursiefen C, Chen L, Borges LP et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113: 1040-50.
20. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230-4.
21. Murakami M, Zheng Y, Hirashima M et al. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol 2008; 28: 658-64.
22. Abtahian F, Guerriero A, Sebzda E et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003; 299: 247-51.
23. Hosking B, Makinen T. Lymphatic vasculature: a molecular perspective. Bioessays 2007; 29: 1192-202.
24. Kubik S, Manestar M. Anatomy of the lymph capillaries and precollectors of the skin. In: Bollinger A, Partsch H, Wolfe JJN, eds. The Initial Lymphatics. Stuttgart: Thieme, 1985: 66-74.
25. Braverman I. The role of blood vessels and lymphatics in cutaneous inflammatory processes: an overview. Br J Dermatol 1983; 109 (Suppl. 25): 89-98.
26. Braverman IM. Ultrastructure and organisation of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989; 93: 25-95.
27. Ryan TJ. Lymphatics and adipose tissue. Clin Dermatol 1995; 13: 493-8.
28. Bollinger A, Jager K, Spier F, Seglias J. Fluorescence microlymphography. Circulation 1981; 64: 1195-200.
29. Tiedjen KU, Knorz S, Heimann KD. The skin: lymphatic collateral organ? Scope Phlebol Lymphol 1994; 1: 7-12.
30. Trzewik J, Mallipattu SK, Artmann GM et al. Evidence for a second valve system in lymphatics: endothelial microvalves. FASEB 200; 15: 1711-7.
31. Barsky SH, Baker A, Siegal GP et al. Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol 1983; 7: 667-77.
32. Ryan TJ. Structure and function of lymphatics. J Invest Dermatol 1989; 93: 18-24.
33. Leak LV, Burke JF. Ultrastructural studies on the lymphatic anchoring filaments. J Cell Biol 1968; 36: 129-49.
34. Weber E, Rossi A, Solito R et al. The pattern of fibrillin deposition correlates with microfibril-associated glycoprotein 1 (MAGP-1) expression in cultured blood and lymphatic endothelial cells. Lymphology 2004; 37: 116-26.
35. Mortimer PS, Cherry GW, Jones RL et al. The importance of elastic fibres in skin lymphatics. Br J Dermatol 1983; 108: 561-6.
36. Daroczy J. The Dermal Lymphatic Capillaries. Berlin: Springer, 1988.
37. Danussi C, Spessotto P, Petrucco A et al. Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol Cell Biol 2008; 28: 4026-39.
38. Hagendoorn J, Padera TP, Kashiwagi S. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 2004; 95: 204-9.
39. Braverman IM. Ultrastructure and organization of the cutaneous micro-vasculature in normal and pathologic states. J Invest Dermatol 1989; 93: 25-95.
40. Lubach D, Wawrzyniak-Schulz A, Neukam D, Nissen S. The extension technique: a new method of demonstrating initial lymph vessels in excised human skin. Br J Dermatol 1990; 123: 179-85.
41. Barsky SH, Baker A, Siegal GP et al. Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol 1983; 7: 667-77.
42. Schlingemann RO, Rietweld FJ, Kwaspen F et al. Differential expression of markers for endothelial cells, pericytes and basal lamina in the microvasculature of tumours and granulation tissue. Am J Pathol 1991; 138: 1335-42.
43. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph specific receptor for hyaluronan. J Cell Biol 1999; 144: 789-801.
44. Breiteneder-Geleff S, Soleman A, Kowalski H et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154: 385-94.
45. Schacht V, Ramirez MI, Hong YK et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003; 22: 3546-56.
46. Wigle JT, Oliver G. Prox-1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-78.
47. Shields JD, Emmett MS, Dunn DB et al. Chemokine-mediated migration of melanoma cells towards lymphatics-a mechanism contributing to metastasis. Oncogene 2007; 26: 2997-3005.
48. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82: 673-700.
49. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med 2004; 4: 448-53.
50. Ikomi F, Schmid-Schonbein GW. Lymph transport in the skin. Clin Dermatol 1995; 13: 419-27.
51. Mora J, Mora R, Lomonte B, Gutiérrez JM. Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation. PLoS Negl Trop Dis 2008; 2: e318.
52. Ikomi F, Schmid-Schonbein GW. Lymph transport in the skin. Clin Dermatol 1995; 13: 419-27.
53. Levick JR, McHale N. The physiology of lymph production and propulsion. In: Browse NL, Burnand KG, Mortimer PS, eds. Diseases of the Lymphatics. London: Arnold, 2003: 44-64.
54. Leak LV. Ultrastructure and function of the interstitial-lymphatic interface. In: Staub NC, Hogg JC, Hargens ASR, eds. Interstitial-Lymphatic Liquid and Solute Movement. Basel: Karger, 1986: 1-14.
55. Castenholz A. Functional microanatomy of initial lymphatics with special consideration of the extracellular matrix. Lymphology 1998; 31: 101-18.
56. Muthuchamy M, Zawieja D. Molecular regulation of lymphatic contractility. Ann N Y Acad Sci 2008; 1131: 89-99.
57. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 2008; 1131: 119-33.
58. Silverberg-Sinakin I, Thorbecke GJ, Baer RL et al. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976; 25: 137-51.
59. Stoitzner P, Pfaller K, Stossel H, Romani N. A close-up view of migrating Langerhans cells in the skin. J Invest Dermatol 2002; 118: 117-25.
60. Smith JB, McIntosh GH, Morris B. The traffic of cells through tissues; a study of peripheral lymph in sheep. J Anat 1970; 107: 87-100.
61. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
62. Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid tissue chemokine (SLC) and cc chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999; 162: 2472-5.
63. Ohl L, Mohaupt M, Czeloth N et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279-88.
64. Worbs T, Mempel TR, Bölter J et al. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007; 204: 489-95.
65. Yoffey JM, Courtice JM. Lymphatics, Lymph and the Lymphomyeloid Complex. New York: Academic Press, 1970.
66. Lambert PB, Frank HA, Bellman S, Farnsworth D. The role of the lymph trunks in the response to allogeneic skin transplants. Transplantation 1965; 3: 62-73.
67. Tilney NL, Gowans JL. The sensitisation of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med 1971; 133: 951-62.
68. Mallon E, Powell S, Mortimer PS, Ryan TJ. Evidence for altered cell mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997; 137: 928-33.
69. Ruocco V, Satriano RA, Astarita C. Anomalies régionales des voies lymphatiques et de la réponse au DNCB dans le sarcoma de Kaposi classique. Ann Dermatol Vénéréol 1985; 112: 283-6.
70. Barnes JM, Trueta J. Absorption of bacteria, toxins and snake venoms from the tissues. Lancet 1941; i: 623-6.
71. De Long TG, Simmons RL. Role of lymphatic vessels in bacterial clearance from early soft tissue infection. Arch Surg 1982; 117: 123-8.
72. Levick JR. An Introduction to Cardiovascular Physiology, 4th edn. London: Arnold, 2003.
73. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med 2004; 4: 448-53.
74. Földi M. Insufficiency of lymph flow. In: Földi M, Casley-Smith JR, eds. Lymphangiology. Stuttgart: Schattauer, 1983: 195-213.
75. Bull RH, Gane JN, Evans J et al. Abnormal lymph drainage in patients with chronic venous leg ulcers. J Am Acad Dermatol 1993; 28: 585-90.
76. Moffatt CJ, Franks PJ, Doherty DC et al. Lymphoedema: an underestimated health problem [abstract]. Br J Dermatol 2002; 147 (Suppl. 62): 8.
77. Dale RF. The inheritance of primary lymphoedema. J Med Genet 1985; 22: 274-8.
78. Scharz U. Die Häufigkeit des primären Lymphödems. Eine epidemiologische Studie an über 1000 Probanden. Med Lymph 1990; 1: 29-34.
79. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci 2008; 1131: 147-54.
80. Mortimer PS, Bates DO, Brassington HD et al. The prevalence of arm swelling following breast cancer treatment. QJM 1996; 89: 377-80.
81. Snijders-Keilholz A, Hellebrekers BW, Zwinderman AH et al. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996). Radiother Oncol 1999; 51: 161-7.
82. Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol 1998; 174: 504-9.
83. Gaarenstroom KN, Kenter GG, Trimbos JB et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003; 13: 522-7.
84. Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol 2002; 167: 1638-42.
85. Allan CP, Hayes AJ, Thomas JM. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. Aust NZ J Surg 2008; 78: 982-6.
86. Wrone DA, Tanabe KK, Cosimi AB et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol 2000; 136: 511-4.
87. Sabel MS, Griffith KA, Arora A et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery 2007; 141: 728-35.
88. Mellor RH, Brice G, Stanton AW et al. Lymphoedema Research Consortium. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007; 115: 1912-20.
89. Altorfer JL, Clodius L. Chronic experimental lymphedema of the extremities: pathological changes. Experientia 1976; 32: 823-5.
90. Olszewski WL. Pathophysiological and clinical observations of obstructive lymphedema of the limbs. In: Clodius L, ed. Lymphedema. Stuttgart: Thieme, 1977: 79-102.
91. Drinker CK, Field ME, Homans J. The experimental production of oedema and elephantiasis as a result of lymphatic obstruction. Am J Physiol 1934; 108: 509-20.
92. Willoughby DA, DiRosa M. A unifying concept for inflammation: a new appraisal of some old mediators. Excerpta Med 1970; 229: 28-38.
93. Casley-Smith JR, Gaffney RM. Excess plasma proteins as a cause of chronic inflammation. J Pathol 1981; 133: 227-72.
94. Daroczy J. Pathology of lymphedema. Clin Dermatol 1995; 13: 433-44.
95. Browse NL, Stewart G. Lymphoedema: pathophysiology and classification. J Cardiovasc Surg 1985; 6: 91-106.
96. Browse NL. The diagnosis and management of primary lymphoedema. J Vasc Surg 1996; 3: 181-4.
97. Brice G, Mansour S, Bell R et al. Analysis of the phenotypic abnormalities in lymphoedema distichiasis syndrome in 74 patients with FOXC-2 mutations or linkage to 16q.24. J Med Genet 2002; 39: 478-83.
98. Milroy WF. Chronic hereditary oedema: Milroy's disease. JAMA 1928; 91: 1172-5.
99. Nonne M. Vier Fälle von Elephantiasis congenita hereditaria. Virchows Arch 1891; 125: 189-96.
100. Ferrell RE, Levinson KL, Esman JH et al. Hereditary lymphoedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 1998; 7: 2073-8.
101. Evans AL, Brice G, Sotirova V et al. Mapping of primary congenital lymphoedema to the 5q.35.3 region. Am J Hum Genet 1999; 64: 547-55.
102. Karkkainen MJ, Ferrell RE, Lawrence EC et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000; 25: 153-9.
103. Dale RF. Primary lymphoedema when found with distichiasis is of the type defined as bilateral hyperplasia by lymphography. J Med Genet 1987; 24: 170-1.
104. Mangion J, Rahman N, Mansour S et al. A gene for lymphedema-distichiasis maps to 16q 24.3. Am J Hum Genet 1999; 65: 427-32.
105. Fang J, Dagenais SL, Erickson RP et al. Mutations in FOXC-2 (MFH-1) a forkhead family transcription factor are responsible for hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000; 67: 1382-8.
106. François M, Caprini A, Hosking B et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008; 456: 643-7.
107. Irrthum A, Devriendt K, Chitayat D et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema- telangiectasia. Am J Hum Genet 2003; 72: 1470-8.
108. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NFκB activation and is a cause of incontinentia pigmenti. Nature 2000; 405: 466-72.
109. Mansour S, Woffendin H, Mitton S et al. Incontentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 2001; 99: 172-7.
110. Meige H. Dystrophie oedemateuse héréditaire. Presse Méd 1898; 6: 341-3.
111. Tartaglia M, Mehler EL, Godberg R et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465-8.
112. Hennekam RCM, Geerdink RA, Hamel BCJ et al. Autosomal recessive intestinal lymphangiectasia and lymphedema with facial anomalies and mental retardation. Am J Med Genet 1989; 34: 593-600.
113. Aagenaes O. Hereditary cholestasis with lymphoedema (Aagenaes syndrome): new cases and follow-up from infancy to adult age. Scand J Gastroent 1998; 33: 335-45.
114. Jarmas AL, Weaver DD, Ellis FD, Davis A. Microcephaly, microphthalmia, falciform retinal folds and blindness: a new syndrome. Am J Dis Child 1981; 135: 930-3.
115. Jackson BT, Kinmonth JB. Pes cavus and lymphoedema. J Bone Joint Surg 1970; 52: 518-20.
116. Wells GC. Yellow nail syndrome with familial primary hypoplasia of lymphatics, manifest late in life. Proc R Soc Med 1966; 59: 447.
117. Zhou XP, Hampel H, Thiele H et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndrome. Lancet 2001; 358: 210-1.
118. Coady MS, Moore MH, Wallis K. Amniotic band syndrome: the association between rare facial clefts and limb ring constrictions. Plast Reconstr Surg 1998; 101: 640-9.
119. Carlton A, St. Elkington JC, Greenfield JG et al. Maffucci's syndrome. QJM 1942; 11: 203-8.
120. Kinmonth JB, Wolfe JH. Fibrosis of the lymph nodes in primary lymphoedema. Br J Surg 1966; 53: 917-25.
121. Fyfe NCM, Wolfe JHN, Kinmonth JB. 'Die-back' in primary lymphoedema. Lymphology 1982; 15: 66-9.
122. Damstra RJ, van Steensel MA, Boomsma JH et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol 2008; 158: 1210-5.
123. Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006; 155: 947-50.
124. Jamal S. Dramatic manifestations of filarial infection. Lymphology 1985; 18: 148-68.
125. Case T, Leis B, Witte M et al. Vascular abnormalities in experimental and human lymphatic filariasis. Lymphology 1991; 24: 174-83.
126. Ngu V, Konstam PG. Chronic lymphoedema in Western Nigeria. Br J Surg 1964; 51: 101-10.
127. Manzoon S, Azadeh B. Elephantiasis of external ear: a rare manifestation of pediculosis capitis. Acta Derm Venereol (Stockh) 1983; 63: 363-5.
128. Nagasaka T, Koyama T, Matsumura K, Chen KR. Persistent lymphoedema in Morbihan disease: formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis. Clin Exp Dermatol 2008; 33: 764-7.
129. Worm AM, Staberg B, Thomsen K. Persistent oedema in allergic contact dermatitis. Contact Dermatitis 1983; 9: 517-8.
130. Price EW. Podoconiosis, Non-Filarial Elephantiasis. Oxford: Oxford University Press, 1990.
131. Bull RH, Coburn PR, Mortimer PS. Pre-tibial myxoedema: a manifestation of lymphoedema? Lancet 1993; 341: 403-4.
132. Kiely PD, Bland JM, Joseph AE et al. Upper limb lymphatic function in inflammatory arthritis. J Rheumatol 1995; 22: 214-7.
133. Mulherin DM, Fitzgerald O, Bresnihan B. Lymphoedema of the upper limb in patients with psoriatic arthritis. Semin Arthritis Rheum 1993; 22: 350-6.
134. Murphy MJ, Kogan B, Carlson JA. Granulomatous lymphangitis of the scrotum and penis. Report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation. J Cutan Pathol 2001; 28: 419-24.
135. Salles AG, Lotierzo PH, Gemperli R et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 2008; 121: 1811-20.
136. Mahoney EM, Edwards EA. Spontaneous regression of leg edema and hydronephrosis following idiopathic retroperitoneal fibrosis. Am J Surg 1962; 103: 514-7.
137. Danese C, Bower R, Howard JM. Experimental anastomoses of lymphatics. Arch Surg 1962; 84: 6-9.
138. Stanton AW, Modi S, Bennett Britton TM et al. Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat 2009; 7: 29-45.
139. Kissin MW, della Rovere GO, Easton D et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-4.
140. Ouvry PA, Guenneguez H. Lymphatic complications from variceal surgery. Phlebologie 1993; 46: 563-8.
141. Reading G. Secrétan's syndrome: hard edema of the dorsum of the hand. Plast Reconstr Surg 1980; 65: 182-7.
142. Bull RH, Gane JN, Evans J et al. Abnormal lymph drainage in patients with chronic venous leg ulcers. J Am Acad Dermatol 1993; 28: 585-90.
143. Bollinger A, Isrensing G, Franzeck U. Lymphatic microangiopathy: a complication of chronic venous insufficiency. Lymphology 1982; 15: 60-5.
144. Bossuyt L, Van Den Oord JJ, Degreef H. Lymphangioma like variant of AIDSassociated Kaposi's sarcoma with pronounced oedema formation. Dermatology 1995; 190: 324-6.
145. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 2006; 126: 2167-77 [Review].
146. Sneddon I, Church R. Practical Dermatology, 4th edn. London: Arnold, 1983: 166.
147. Bull RH, Mortimer PS. Acute lipodermatosclerosis in a pendulous abdomen. Clin Exp Dermatol 1993; 18: 164-6.
148. Mortimer PS. Managing lymphoedema. Clin Exp Dermatol 1995; 20: 98-106.
149. Stemmer R. Ein klinisches Zeichen zur Früh- und Differentialdiagnose des Lymphödems. Vasa 1976; 5: 261-2.
150. Baddour LM, Bisno AL. Non-group A β-haemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med 1985; 79: 155-9.
151. Edwards EA. Recurrent febrile episodes and lymphoedema. JAMA 1963; 184: 858-62.
152. Krywonis N, Kaye VN, Lynch PJ. Cryptococcal cellulitis in congenital lymphoedema. Int J Dermatol 1990; 29: 41-4.
153. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphoedema. Cancer 1948; 1: 64-81.
154. Benson PM, Pessoa CM, Lupton GP et al. Basal cell carcinomas arising in chronic lymphoedema. J Dermatol Surg Oncol 1988; 14: 781-3.
155. Epstein JL, Mendelsohn G. Squamous carcinoma of the foot arising in association with longstanding verrucous hyperplasia in a patient with congenital lymphoedema. Cancer 1984; 54: 943-7.
156. Waxman M, Fatteh S, Elias JM et al. Malignant lymphoma of skin associated with postmastectomy lymphoedema. Arch Pathol Laboratory Med 1984; 108: 206-8.
157. Tatnall FM, Mann BS. Non-Hodgkin's lymphoma of the skin associated with chronic limb lymphoedema. Br J Dermatol 1985; 113: 751-6.
158. Hills RJ, Ive FA. Cutaneous secondary follicular centre cell lymphoma in association with lymphoedema praecox. Br J Dermatol 1993; 129: 186-9.
159. Sarkany I. Malignant melanomas in lymphoedematous arm following radical mastectomy for breast carcinoma. J R Soc Med 1972; 65: 253-4.
160. Bartal AH, Pinsky CM. Malignant melanoma appearing in a postmastectomy lymphoedematous arm: a novel association of double primary tumours. J Surg Oncol 1985; 30: 16-8.
161. Fergusson CM, Copeland SA, Horton L. Unusual sarcoma arising in lymphoedema. J R Soc Med 1985; 78: 1497-8.
162. Merimsky O, Chaitchik S. Kaposi's sarcoma on a lymphoedematous arm following radical mastectomy. Tumori 1992; 78: 407-8.
163. Shreiber H, Barry FM, Russell WC et al. Stewart-Treves syndrome: a lethal complication of post mastectomy lymphoedema and regional immune defi- ciency. Arch Surg 1979; 114: 82.
164. Tatnall FM, Sarkany I. Primary focal lymphoedema with xanthoma. J R Soc Med 1988; 81: 113-4.
165. Callens A, Vaillant L, Machet MC et al. Localized atypical pemphigoid on lymphoedema following radiotherapy. Acta Derm Venereol (Stockh) 1993; 73: 461-4.
166. Wilkinson SM, Heagarty AH, Smith AG. Toxic epidermal necrolysis localized to an area of lymphoedema. Clin Exp Dermatol 1991; 17: 456-7.
167. Demitsu T, Tadaki T. Atypical neutrophilic dermatosis on the upper extremity affected by post-mastectomy lymphoedema: report of 2 cases. Dermatologica 1991; 183: 230-3.
168. Kaier T, Larsen J. Necrotizing fasciitis in congenital lymphoedema. Int J Dermatol 1990; 29: 41-4.
169. Connelly MG, Winkelmann RK. Solid facial edema as a complication of acne vulgaris. Arch Dermatol 1985; 121: 87-90.
170. Nagasaka T, Koyama T, Matsumura K, Chen KR. Persistent lymphoedema in Morbihan disease: formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis. Clin Exp Dermatol 2008; 33: 764-7.
171. Dozsa A, Karoli ZS, Degrell P. Bilateral blepharochalasis. J Eur Acad Dermatol Venereol 2005; 19: 725-8.
172. Carlson JA, Mazza J, Kircher K, Tran TA. Otophyma: a case report and review of the literature of lymphoedema (elephantiasis) of the ear. Am J Dermatopathol 2008; 30: 67-72.
173. Nozicka Z. Endovasal granulomatous lymphangitis as a pathogenetic factor in cheilitis granulomatosa. J Oral Pathol 1985; 14: 363-5.
174. Orosz Z, Lehoczky O, Szoke J, Pulay T. Recurrent giant fibroepithelial stromal polyp of the vulva associated with congenital lymphedema. Gynecol Oncol 2005; 98: 168-71.
175. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 2004; 10: 405-11.
176. Farshid G, Weiss SW. Massive localized lymphedema in the morbidly obese: a histologically distinct reactive lesion simulating liposarcoma. Am J Surg Pathol 1998; 22: 1277-83.
177. Lu S, Tran Ta, Jones DM et al. Localized lymphedema (elephantiasis): a case series and review of the literature. J Cutan Pathol 2008; 36: 1-20.
178. Warren Ag, Slavin SA. Scar lymphedema: fact or fiction? Ann Plast Surg 2007; 59: 41-5.
179. Stewart G, Gaunt J, Croft DN et al. Isotope lymphography: a new method of investigating the role of lymphatics. Br J Surg 1985; 72: 906-9.
180. Proby CM, Gane JN, Joseph AE et al. Investigation of the swollen limb with isotope lymphography. Br J Dermatol 1990; 123: 29-38.
181. Vaughan BF. CT of swollen legs. Clin Rad 1990; 41: 24-30.
182. Duewell S, Hagspiel KD, Zuber J et al. Swollen limb extremity: role of MR imaging. Radiology 1992; 184: 227-31.
183. Kinmonth JB. Lymphangiography in man. Clin Sci 1952; 11: 13-20.
184. Lohrmann C, Felmerer G, Foeldi E et al. MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstruction of lymphatic vessels. Microvasc Res 2008; 76: 42-5.
185. Lu Q, Xu J, Liu N. Chronic lower extremity lymphedema: a comparative study of high-resolution interstitial MR lymphangiography and heavily T2-weighted MRI. Eur J Radiol 2008. (Epub ahead of print.)
186. Hudack SS, McMaster PD. Lymphatic participation in human cutaneous phenomena. J Exp Med 1933; 57: 751-74.
187. Bollinger A, Jager K, Spier F, Seglias J. Fluorescence microlymphography. Circulation 1981; 64: 1195-200.
188. Partsch HT, Urbanek A, Wenzel-Hora B. The dermal lymphatics in lymphoedema visualized by indirect lymphography. Br J Dermatol 1984; 110: 431-8.
189. Partsch H, Stoberl CL, Urbanek A et al. Clinical use of indirect lymphography in different forms of leg oedema. Lymphology 1988; 21: 152-60.
190. Costa da Cunha Castro E, Galambos C. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations-a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009; 12: 187-94.
191. Wold LE, Hines EA, Allen EV. Lipoedema of the legs. Ann Intern Med 1949; 34: 1243-50.
192. Kröger K. Lymphoedema and lipoedema of the extremities. VASA 2008; 37: 39-51.
193. Harwood CA, Bull RH, Evans J et al. Lymphatic and venous function in lipoedema. Br J Dermatol 1996; 134: 1-6.
194. Schmeller W, Meier-Vollrath I. Tumescent liposuction: a new and successful therapy for lipedema. J Cutan Med Surg 2006; 10: 7-10.
195. Wortham NC, Tomlinson IP. Dercum's disease. Skinmed 2005; 4: 157-62.
196. Hayes SB, Freedman GM, Li T et al. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys 2008; 72: 1449-55.
197. Shaw C, Mortimer P, Judd PA. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 2007; 110: 1868-74.
198. Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 2007; 109: 1949-56.
199. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med 2004; 4: 448-53.
200. Emerson PA. Yellow nails, lymphoedema and pleural effusions. Thorax 1966; 21: 247-53.
201. Bull RH, Fenton DA, Mortimer PS. Lymphatic function in the yellow nail syndrome. Br J Dermatol 1996; 134: 307-12.
202. Medical Education Partnership. Best Practice for the Management of Lymphoedema: International Consensus. London: MEP Ltd, 2006. www.library.nhs.uk
203. Clinical Resource Efficiency Support Team. Guidelines on the Diagnosis, Assessment and Management of Lymphoedema, 2008. www.crestni.org.uk
204. Foldi E, Foldi M, Weissleder H. Conservative treatment of lymphoedema of the limbs. Angiology 1985; 36: 171-80.
205. Mortimer P, Todd J. Lymphoedema: Advice on Self-management and Treatment, 3rd edn. Beaconsfield: Beaconsfield Publishers, 2007.
206. Ikomi F, Schmid-Schonbein GW. Lymph transport in skin. Clin Dermatol 1995; 13: 419-27.
207. Roddie IC. Lymph transport mechanisms in peripheral lymphatics. News Physiol Sci 1990; 5: 85-9.
208. Badger CMA, Peacock JL, Mortimer PS. A randomized, controlled, parallel group clinical trial comparing multi-layer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer 2000; 88: 2832-7.
209. Anonymous. Compression for lymphoedema. Lancet 1986; i: 896.
210. Mortimer PS, Simmonds R, Rezvani M et al. Measurement of skin lymph flow by an isotope clearance technique: reliability, reproducibility effect of injection dynamics and lymph flow enhancement. J Invest Dermatol 1990; 95: 677-82.
211. Tiedjen KU, Knorz S, Heimann KD. The skin: lymphatic collateral organ? Scope Phlebol Lymphol 1994; 1: 7-12.
212. Shaw C, Mortimer P, Judd PA. A randomised controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 2007; 110: 1868-74.
213. Shaw C, Mortimer P, Judd PA. Randomised controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 2007; 109: 1949-56.
214. Gothard L, Stanton A, MacLaren J et al. Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol 2004; 70: 217-24.
215. Carati CJ, Anderson SN, Gannon BJ, Piller NB. Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. Cancer 2003; 98: 1114-22. [Erratum Cancer 2003; 98: 2742.]
216. Kozanoglu E, Basaran S, Paydas S, Sarpel T. Efficacy of pneumatic compression and low-level laser therapy in the treatment of postmastectomy lymphoedema: a randomized controlled trial. Clin Rehabil 2009; 23: 117-24.
217. Tsai HJ, Hung HC, Yang JL et al. Could Kinesio tape replace the bandage in decongestive lymphatic therapy for breast-cancer-related lymphedema? A pilot study. Support Care Cancer 2009. [Epub ahead of print.]
218. Rockson S, Miller L, Senie R. Workshop III: diagnosis and management of lymphedema. Cancer 1998; 83 (Suppl.): 282-5.
219. Hornsby R. The use of compression to treat lymphoedema. Prof Nurse 1995; 11: 127-8.
220. Williams AF, Vadgama A, Franks P, Mortimer PS. A randomized controlled cross-over study of manual lymphatic drainage therapy in women with breast cancer-related lympoedema. Eur J Cancer Care 2002; 11: 254-61.
221. Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer related lymphoedema with or without manual lymph drainage: a randomized study. Acta Oncol 2000; 39: 399-405.
222. Dini D, Del Mastro L, Gozza A et al. The role of pneumatic compression in the treatment of postmastectomy lymphedema: a randomized phase III study. Ann Oncol 1998; 9: 187-90.
223. Whitaker J. Best practice in managing scrotal lymphoedema. Br J Community Nurs 2007; 12 (Suppl.): S17-21.
224. Collin JR. Blepharochalasis. A review of 30 cases. Ophthal Plast Reconstr Surg 1991; 7: 153-7.
225. Medical Education Partnership. Best Practice for the Management of Lymphoedema: International Consensus. London: MEP Ltd, 2006. http://www.library.nhs.uk
226. Clinical Resource Efficiency Support Team. Guidelines on the Diagnosis, Assessment and Management of Lymphoedema, 2008. http://www.crestni.org.uk
227. British Lymphology Society. Consensus Document on the Management of Cellulitis in Lymphoedema. http://www.thebls.com/concensus.php
228. Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol Venereol 2006; 20: 818-22.
229. Shenoy RK, Suma TK, Rajan K et al. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine each combined with local treatment of the affected limb. Ann Trop Med Parasit 1998; 92: 587-94.
230. Shenoy RK, Kumaraswami V, Suma TK et al. A double blind placebo controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasit 1999; 93: 367-77.
231. Mortimer PS, Badger C, Clarke I, Pallett J. A double blind, randomized, parallel group, placebo-controlled trial of O-(-β hydroxyethyl)-rutosides in chronic arm oedema resulting from breast cancer treatment. Phlebology 1995; 10: 51-5.
232. Loprinzi CL, Kugler JW, Sloan JA et al. Lack of effect of coumarin in women with lymphoedema after treatment for breast cancer. N Eng J Med 1999; 340: 346-50.
233. Browse NL, Burnand KG, Mortimer PS. Diseases of the Lymphatics. London, Arnold, 2003.
234. Brorson H, Ohlin K, Olsson G et al. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology 2008; 41: 52-63.
235. Garaffa G, Christopher N, Ralph DJ. The management of genital lymphoedema. BJU Int 2008; 102: 480-4.
236. Campisi C. Use of autologous interposition vein graft in management of lymphedema: preliminary experimental and clinical observations. Lymphology 1991; 24: 71-6.
237. Baumeister RG, Siuda S. Treatment of lymphedema by microsurgical lymphatic grafting: what is proved? Plast Reconstr Surg 1990; 85: 75-6.
238. Nagase T, Gonda K, Inoue K et al. Treatment of lymphedema with lymphaticovenular anastomoses. Int J Clin Oncol 2005; 10: 304-10.
239. Enjolras O, Wassef M, Chapot R. Color Atlas of Vascular Tumors and Vascular Malformations. Cambridge: Cambridge University Press, 2007.
240. Lee BB, Kim YW, Seo JM et al. Current concepts in lymphatic malformation. Vasc Endovasc Surg 2005; 39: 67-81.
241. Blei F. Congenital lymphatic malformations. Ann N Y Acad Sci 2008; 1131: 185-94.
242. Garzon M, Huang J, Enjolras O, Frieden I. Vascular malformations, part I. J Am Acad Dermatol 2007; 56: 353-70.
243. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007; 16: 140-9.
244. Marler J, Mulliken J. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005; 32: 99-116.
245. Wiegand S, Eivazi B, Barth P et al. Pathogenesis of lymphangioma. Virchows Arch 2008; 453: 1-8.
246. Peachey RC, Lim CC, Whimster IM. Lymphangiomas of the skin. Br J Dermatol 1970; 83: 519-27.
247. Wilson GR, Cox NH, McLean NR et al. Squamous cell carcinoma arising within lymphangioma circumscriptum. Br J Dermatol 1993; 129: 337-9.
248. Whimster I. The pathology of lymphangioma circumscriptum. Br J Dermatol 1976; 94: 473-86.
249. McAlvanny JP, Jorizzo JL, Zanoll D et al. Magnetic resonance imaging in the evaluation of lymphangioma circumscriptum. Arch Dermatol 1993; 129: 194-7.
250. Browse NL, Whimster I, Stewart G et al. Surgical management of 'lymphangioma circumscriptum'. Br J Surg 1986; 73: 585-8.
251. Molitch HL, Unger ES, Witte CL et al. Percutaneous sclerotherapy of lymphangiomas. Radiology 1995; 194: 343-7.
252. Mikhail M, Kennedy R, Cramer B et al. Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg 1995; 30: 1159-60.
253. Bikowski J, Dumont M. Lymphangioma circumscriptum: treatment with hypertonic saline sclerotherapy. J Am Acad Dermatol 2005; 53: 442-4.
254. O'Cathail S, Rostom AY, Johnson ML. Successful control of lymphangioma circumscriptum by superficial x-rays. Br J Dermatol 1985; 113: 611-5.
255. Chervanak FA, Isaacson G, Blakemore KJ et al. Fetal cystic hygroma, cause and natural history. N Engl J Med 1983; 309: 822-5.
256. Irvine AD, Sweeney L, Corbett J. Lymphangioma circumscriptum associated with paravesical cystic retroperitoneal lymphangioma. Br J Dermatol 1996; 134: 1135-7.
257. Blei F. Congenital lymphatic malformations. Ann N Y Acad Sci 2008; 1131: 185-94.
258. Greene A, Burrows P, Smith L, Mulliken J. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg 2005; 115: 22-30.
259. North P, Kahn T, Cordisco M et al. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinico-pathological entity. Arch Dermatol 2004; 140: 599-606.
260. Alvarez O, Kjellin I, Zuppan C. Thoracic lymphangiomatosis in a child. J Pediatr Hematol Oncol 2004; 26: 136-41.
261. Mazreeuw-Hautier J, Syed S, Leisner R, Harper J. Extensive venous/lymphatic malformations causing life-threatening haematological complications. Br J Dermatol 2007; 157: 558-63.
262. Bruch-Gerharz D, Gerharz C, Stege H et al. Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndrome. J Am Acad Dermatol 2007; 56 (Suppl. 2): S21-5.
263. Ozeki M, Ito M, Teramoto T et al. Clinical improvement of difuse lymphangiomatosis with pegylated interferon alpha-2b therapy. J Pediatr Hematol Oncol 2007; 24: 513-24.
264. Browse NL. Management of lymph and chyle reflux. In: Browse NL, Burnand KG, Mortimer PS, eds. Diseases of the Lymphatics. London: Arnold, 2003: 259-92.
265. Lee J, Kong MS. Primary intestinal lymphangiectasia diagnosed by endoscopy following the intake of a high-fat meal. Eur J Pediatr 2008; 167: 237-9.
266. Bliss CM, Schroy PC III. Primary intestinal lymphangiectasia. Curr Treat Options Gastroenterol 2004; 7: 3-6.
267. Van Balkom ID, Alders M, Allanson J et al. Lymphedema-lymphangiectasiamental retardation (Hennekam) syndrome: a review. Am J Med Genet 2002; 112: 412-21.
268. Safatle-Ribeiro AV, Iriya K, Couto DS et al. Secondary lymphangiectasia of the small bowel: utility of double balloon enteroscopy for diagnosis and management. Dig Dis 2008; 26: 383-6.
269. Diaz-Cascajo C, Borghi S, Weyers W et al. Benign lymphangiomatous papules of the skin following radiotherapy: a report of five new cases and review of the literature. Histopathology 1999; 35: 319-27.
270. Gengler C, Coindre JM, Leroux A et al. Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group. Cancer 2007; 109: 1584-98.
271. Mallett RB, Curley RK, Mortimer PS. Acquired lymphangiomata: report of four cases and a discussion of the pathogenesis. Br J Dermatol 1992; 126: 380-2.
272. El Sayed F, Basex J, Bouissou X et al. Acquired cutaneous lymphangiectasia mimicking plantar warts. Br J Dermatol 1996; 132: 1014-6.
273. Goldstein JB, McNatt NS, Hambrick GW. Penicillamine dermopathy with lymphangiectases. Arch Dermatol 1989; 125: 92-7.
274. Harwood CA, Mortimer PS. Acquired vulval lymphangiomata mimicking genital warts. Br J Dermatol 1993; 129: 334-6.
275. Makh DS, Mortimer P, Powell B. A review of the surgical treatment of vulval lymphangioma and lymphangiectasia: four case reviews. J Plast Reconstr Aesthet Surg 2006; 59: 1442-5.
276. Damstra RJ, van Steensel MA, Boomsma JH et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol 2008; 158: 1210-5.
277. Cox NH. Streptococcal cellulitis in reticulate lymphoedema selectively affects the lymphoedematous herniations. Br J Dermatol 1998; 139: 358-9.
278. British Lymphology Society. Consensus Document on the Management of Cellulitis in Lymphoedema. http://www.thebls.com/concensus.php
279. Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol Venereol 2006; 20: 818-22.
280. Marsch W, Haas N, Stuttgen G. Mondor's phlebitis: a lymphovascular process. Dermatologica 1986; 172: 133-8.
281. Moskovitz AH, Anderson BO, Yeung RS et al. Axillary web syndrome after axillary dissection. Am J Surg 2001; 181: 434-9.
282. Ferguson JH, Maclure JG. Lymphocele following lymphadenectomy. Am J Obstet Gynecol 1961; 82: 783-92.
283. Goh S, Calonje E. Cutaneous vascular tumours: an update. Histopathology 2008; 52: 661-73.
284. Wilson Jones E, Winkelmann RK, Zachary CB et al. Benign lymphangio-endothelioma. J Am Acad Dermatol 1990; 23: 229-34.
285. Guillou L, Fletcher CD. Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series. Am J Surg Pathol 2000; 24: 1047-57.
286. Joliat G, Stalder H, Kapanci Y. Lymphangiomyomatosis: a clinico-anatomical entity. Cancer 1973; 31: 455-61.
287. Glasgow C, Taveiro-Dasilva A, Darling T, Moss J. Lymphatic involvement in lymphangiomyomatosis. Ann N Y Acad Sci 2008; 1131: 206-14.
288. Bissler JJ, McCormack FX, Young LR et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-51.
289. Skobe M, Brown LF, Tognazzi K et al. Vascular endothelial growth factor (VEGFC) and its receptor KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J Invest Dermatol 1999; 113: 1047-53.
290. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 2006; 126: 2167-77.
291. Carlton A, St Elkington JC, Greenfield JG et al. Maffucci's syndrome. QJM 1942; 11: 203-28.
292. Gengler C, Coindre J-M, Leroux A. Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process. Cancer 2007; 109: 1584-98.
293. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphoedema. Cancer 1948; 1: 64-81.
294. Eby CS, Brennan MJ, Fine G. Lymphangiosarcoma: lethal complication of chronic lymphedema: report of two cases and review of the literature. Arch Surg 1967; 94: 223-30.
295. Lans TE, de Wilt JH, van Geel AN, Eggermont AM. Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Sewart-Treves lymphangiosarcoma. Ann Surg Oncol 2002; 9: 1004-9.
296. Finkel LJ, Griffiths CEM. Inflammatory breast carcinoma (carcinoma erysipeloides), an easily overlooked diagnosis. Br J Dermatol 1993; 129: 324-6.
297. Marneros AG, Blanco F, Husain S et al. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels. J Am Acad Dermatol 2009; 60: 633-8.